Similar articles

• The influence of some physico-chemical factors on the biliary excretion of a series of structurally related aryl sulphate esters.

  Hearse DJ, Powell GM, Olavesen AH, Dodgson KS. Hearse DJ, et al. Biochem Pharmacol. 1969 Jan;18(1):181-95. doi: 10.1016/0006-2952(69)90023-9. Biochem Pharmacol. 1969. PMID: 4889090 No abstract available.
• The preparation and characterization of a series of 35S-labelled aryl sulphate esters for metabolic studies.

  Hearse DJ, Olavesen AH, Powell GM. Hearse DJ, et al. Biochem Pharmacol. 1969 Jan;18(1):173-80. doi: 10.1016/0006-2952(69)90022-7. Biochem Pharmacol. 1969. PMID: 5769346 No abstract available.
• The mode of excretion and metabolic fate of potassium naphthyl 2-35S-sulphate and potassium 5,6,7,8-tetrahydronaphthyl 2-35S-sulphate.

  Hearse DJ, Powell GM, Olavesen AH. Hearse DJ, et al. Biochem Pharmacol. 1969 Jan;18(1):197-203. doi: 10.1016/0006-2952(69)90024-0. Biochem Pharmacol. 1969. PMID: 4889091 No abstract available.
• The effect of a structural modification on the metabolism and mode of excretion of naphthyl 2[35S]-sulphate.

  Hearse DJ, Powell GM, Olavesen AH. Hearse DJ, et al. Biochem J. 1968 Sep;109(3):36P-37P. doi: 10.1042/bj1090036p. Biochem J. 1968. PMID: 5685860 Free PMC article. No abstract available.
• The distribution of 35S-labelled sulphuric acid esters administered to mice and rats.

  Powell GM, Curtis CG, Dodgson KS. Powell GM, et al. Biochem Pharmacol. 1967 Oct;16(10):1997-2001. doi: 10.1016/0006-2952(67)90311-5. Biochem Pharmacol. 1967. PMID: 6065964 No abstract available.